Skip to content

Mannkind MNKD Price / sales

Price / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.4×-3.8×
LQD
Liquidia CorporationLQDA
11.5×-77.4×
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
9.5×+4.2×
Opko Health logo
Opko HealthOPK
1.5×-0.1×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
7.7×+0.5×
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
2.6×

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Calculated from Mannkind’s reported figures.

Based on the most recent quarter.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's price / sales?
Mannkind (MNKD) reported price / sales of 2.1× in Q1 2026.
How has Mannkind's price / sales changed year-over-year?
Mannkind's price / sales decreased by 59.2% year-over-year, from 5.1× to 2.1×.
What is the long-term trend for Mannkind's price / sales?
Over 5 years (2020 to 2025), Mannkind's price / sales has grown at a -16.2% compound annual growth rate (CAGR), from 12.1× to 5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.